236 related articles for article (PubMed ID: 20218907)
1. Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion.
Morganti RP; Cardoso MH; Pereira FG; Lorand-Metze I; De Nucci G; Marcondes S; Antunes E
Platelets; 2010; 21(4):260-9. PubMed ID: 20218907
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen and nitrogen species modulate the ex-vivo effects of LPS on platelet adhesion to fibrinogen.
Casarin AL; Lopes-Pires ME; Morganti RP; Antunes E; Marcondes S
Life Sci; 2011 Nov; 89(21-22):773-8. PubMed ID: 21958470
[TBL] [Abstract][Full Text] [Related]
3. The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.
Cardoso MH; Morganti RP; Lilla S; Murad F; De Nucci G; Antunes E; Marcondes S
Eur J Pharmacol; 2010 Feb; 627(1-3):229-34. PubMed ID: 19895807
[TBL] [Abstract][Full Text] [Related]
4. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADP-induced platelet adhesion to immobilised fibrinogen by nitric oxide: evidence for cGMP-independent mechanisms.
Oberprieler NG; Roberts W; Graham AM; Homer-Vanniasinkam S; Naseem KM
Biochem Pharmacol; 2007 May; 73(10):1593-601. PubMed ID: 17306768
[TBL] [Abstract][Full Text] [Related]
6. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
7. A colorimetric method for the measurement of platelet adhesion in microtiter plates.
Bellavite P; Andrioli G; Guzzo P; Arigliano P; Chirumbolo S; Manzato F; Santonastaso C
Anal Biochem; 1994 Feb; 216(2):444-50. PubMed ID: 8179202
[TBL] [Abstract][Full Text] [Related]
8. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Ito H; Miyakoda G; Mori T
Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide treatment reduces rat platelet aggregation independent of intracellular reactive-oxygen species generation.
Lopes-Pires ME; Casarin AL; Pereira-Cunha FG; Lorand-Metze I; Antunes E; Marcondes S
Platelets; 2012; 23(3):195-201. PubMed ID: 21806496
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of staphylococcal enterotoxin type B on human platelet adhesion in vitro.
Morganti RP; Marcondes S; Baldasso PA; Marangoni S; De Nucci G; Antunes E
Platelets; 2008 Sep; 19(6):432-9. PubMed ID: 18925511
[TBL] [Abstract][Full Text] [Related]
13. Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS.
Begonja AJ; Teichmann L; Geiger J; Gambaryan S; Walter U
Blood Cells Mol Dis; 2006; 36(2):166-70. PubMed ID: 16469512
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
15. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
16. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions.
Díaz-Ricart M; Estebanell E; Lozano M; Aznar-Salatti J; White JG; Ordinas A; Escolar G
Haematologica; 2000 Mar; 85(3):280-8. PubMed ID: 10702817
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.
Sill JC; Proper JA; Johnson ME; Uhl CB; Katusic ZS
Platelets; 2007 Dec; 18(8):613-9. PubMed ID: 18041653
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
19. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
